| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |